Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
683 Capital Management, LLC (CIK 1404574) reported $1.92B across 174 reported positions in its SEC 13F filing for 2026-03-31. Largest positions: PLTR ($340.6M, 17.78%), LLY ($137.0M, 7.15%), NVDA ($79.5M, 4.15%), COF ($68.4M, 3.57%), ALNY ($49.3M, 2.57%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | PLTR | PALANTIR TECHNOLOGIES INC | $340.6M | 17.78% | 2.3M | Hold |
| 2 | LLY | ELI LILLY & CO | $137.0M | 7.15% | 149,000 | Trimmed |
| 3 | NVDA | NVIDIA CORPORATION | $79.5M | 4.15% | 456,000 | Hold |
| 4 | COF | CAPITAL ONE FINL CORP | $68.4M | 3.57% | 375,000 | Trimmed |
| 5 | ALNY | ALNYLAM PHARMACEUTICALS INC | $49.3M | 2.57% | 149,100 | Added |
| 6 | CVNA | CARVANA CO | $48.7M | 2.54% | 155,000 | Added |
| 7 | MDGL | MADRIGAL PHARMACEUTICALS INC | $47.1M | 2.46% | 90,000 | Trimmed |
| 8 | TSLA | TESLA INC | $40.9M | 2.13% | 110,000 | Trimmed |
| 9 | BBIO | BRIDGEBIO PHARMA INC | $39.2M | 2.05% | 21.8M | Hold |
| 10 | PTGX | PROTAGONIST THERAPEUTICS INC | $39.0M | 2.04% | 370,100 | Trimmed |
| 11 | PRAX | PRAXIS PRECISION MEDICINES I | $36.3M | 1.90% | 112,700 | Trimmed |
| 12 | WVE | WAVE LIFE SCIENCES LTD | $35.5M | 1.85% | 4.9M | Added |
| 13 | BDX | BECTON DICKINSON & CO | $35.4M | 1.85% | 225,000 | Added |
| 14 | KSPI | KASPI KZ JSC | $35.2M | 1.84% | 475,000 | Added |
| 15 | ANAB | ANAPTYSBIO INC | $34.7M | 1.81% | 625,000 | Trimmed |
| 16 | HGV | HILTON GRAND VACATIONS INC | $30.3M | 1.58% | 775,000 | Added |
| 17 | QURE | UNIQURE NV | $28.7M | 1.50% | 1.8M | Added |
| 18 | GXO | GXO LOGISTICS INCORPORATED | $25.9M | 1.35% | 500,000 | Trimmed |
| 19 | AMLX | AMYLYX PHARMACEUTICALS INC | $22.6M | 1.18% | 1.6M | Trimmed |
| 20 | MGTX | MEIRAGTX HLDGS PLC | $21.2M | 1.11% | 2.5M | Trimmed |
| 21 | MOH | MOLINA HEALTHCARE INC | $21.3M | 1.11% | 160,000 | Added |
| 22 | PHAT | PHATHOM PHARMACEUTICALS INC | $20.6M | 1.07% | 1.9M | Added |
| 23 | AMTM | AMENTUM HOLDINGS INC | $20.2M | 1.05% | 775,000 | Trimmed |
| 24 | IAG | IAMGOLD CORP | $19.8M | 1.03% | 1.1M | Added |
| 25 | TGTX | TG THERAPEUTICS INC | $19.6M | 1.02% | 590,000 | Added |
Source: SEC Form 13F filings · as of 2026-03-31